Teva's Woes Extend Beyond CEO's Sudden Departure

If Teva's next chief fails to put the drug giant on a growth track, the Israeli firm may end up in foreign hands.

There was no lack of drama and ego. Only two days after telling the entire world that there was no conflict between him and the board of directors, Jeremy Levin, the CEO of Teva Pharmaceutical Industries, announced his immediate resignation.